USD 3.32
(-7.78%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 284.27 Million USD | -38.32% |
2022 | 460.88 Million USD | 12.0% |
2021 | 411.48 Million USD | -50.76% |
2020 | 835.63 Million USD | 708203.31% |
2019 | 117.97 Thousand USD | -99.96% |
2018 | 265.42 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 349.32 Million USD | -7.9% |
2024 Q1 | 379.29 Million USD | 33.42% |
2023 FY | 284.27 Million USD | -38.32% |
2023 Q4 | 284.27 Million USD | -61.48% |
2023 Q2 | 927.42 Million USD | -17.96% |
2023 Q1 | 1.13 Billion USD | 145.29% |
2023 Q3 | 737.94 Million USD | -20.43% |
2022 Q4 | 460.88 Million USD | -60.46% |
2022 Q3 | 1.16 Billion USD | -28.76% |
2022 Q2 | 1.63 Billion USD | -25.29% |
2022 FY | 460.88 Million USD | 12.0% |
2022 Q1 | 2.19 Billion USD | 432.24% |
2021 Q1 | 278 Million USD | -66.73% |
2021 FY | 411.48 Million USD | -50.76% |
2021 Q4 | 411.48 Million USD | -23.83% |
2021 Q3 | 540.18 Million USD | -40.05% |
2021 Q2 | 901.04 Million USD | 224.11% |
2020 Q2 | 384.23 Million USD | 325582.97% |
2020 Q1 | 117.97 Thousand USD | -99.97% |
2020 FY | 835.63 Million USD | 708203.31% |
2020 Q4 | 835.63 Million USD | 127.94% |
2020 Q3 | 366.6 Million USD | -4.59% |
2019 Q4 | 377.81 Million USD | 0.0% |
2019 FY | 117.97 Thousand USD | -99.96% |
2019 Q1 | - USD | 0.0% |
2018 FY | 265.42 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Alignment Healthcare, Inc. | 433.8 Million USD | 34.47% |
Marpai, Inc. | 45.11 Million USD | -530.082% |
NewGenIvf Group Limited | 5.72 Million USD | -4868.33% |